See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Donald Trump
Social Media
Tariffs
Natural Disasters
South America
Vladimir Putin
European Union
Weapons
Education
Inflation
Infrastructure
Published • loading... • Updated

The Tyruko-Tysabri SH1-Show Part I. PML tests

Summary by Multiple Sclerosis Research Blog
This week we have been looking at the SH1 show created by the makers of Natalizumab. Tysabri was the original and as its patents ran out Tyruko was made and NICE said “use it”. However …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Multiple Sclerosis Research BlogMultiple Sclerosis Research Blog

The Tyruko-Tysabri SH1-Show Part I. PML tests

This week we have been looking at the SH1 show created by the makers of Natalizumab. Tysabri was the original and as its patents ran out Tyruko was made and NICE said “use it”. However …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Multiple Sclerosis Research Blog broke the news in on Thursday, July 10, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tweet icon

Tweet

Italy icon

Italy

News
For You
SearchBlindspotLocal